Evaluation of miR-16 as an internal control in the patients with breast cancer

Hum Pathol. 2019 Mar:85:329. doi: 10.1016/j.humpath.2018.10.034. Epub 2018 Nov 17.

Authors

Soheil Madadi¹, Meysam Soleimani²

Affiliations

¹ Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
² Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: m.soleymani@umsha.ac.ir.

PMID: 30458198
DOI: 10.1016/j.humpath.2018.10.034

No abstract available

Keywords: Endogenous miR-16; Serum microRNA normalization.

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms*
Humans
MicroRNAs*
Neoadjuvant Therapy
Prognosis

Substances

MIRN16 microRNA, human
MIRN21 microRNA, human
MicroRNAs